Marek Poszepcynski joined SV Health Investors in 2013, working as an portfolio manager for International Biotechnology Trust plc. Marek was appointed as Joint Lead Investment Manager of the Trust in March 2021.
His primary role is to analyse companies, with a particular focus on identifying potential M&A targets. Marek has more than 15 years of international experience in the life sciences industry with a focus on licensing and financing. He held management positions at Handelsbanken (2010-2012) as lead equity analyst, VP Business Development at Karolinska Development AB (2008-2010) and Licensing Director at Biovitrum AB (2002-2008. Marek has participated in two initial public offerings and a number of licensing and asset transfer transactions and received the Swedish Entrepreneurial Distinction 2015 through the founding, running and divesting of a profitable Contract Research Organisation.
Marek holds a MSc in Biochemistry and MSc in Business Management from the Royal Institute of Technology, Stockholm, Sweden.